Revision: Nov. 6, 2023, 10:36 a.m.
2024 SESSION
24-2186.1
05/10
HOUSE BILL [bill number]
AN ACT relative to insurance coverage for diagnostic and supplemental breast examinations.
SPONSORS: [sponsors]
COMMITTEE: [committee]
─────────────────────────────────────────────────────────────────
ANALYSIS
This bill provides that certain insurers that provide diagnostic and supplemental breast examinations shall not impose co-payments, deductibles, or other cost-sharing requirements.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
24-2186.1
05/10
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Four
AN ACT relative to insurance coverage for diagnostic and supplemental breast examinations.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Section; Women's Health Care; Coverage for Diagnostic and Supplemental Breast Examinations. Amend RSA 417-D by inserting after section 2-b the following new section:
417-D:2-c Coverage for Diagnostic and Supplemental Breast Examinations.
I. No group health plan, or a health insurance issuer offering group or individual health insurance coverage, that provides benefits with respect to screening and diagnostic and supplemental breast examinations furnished to an individual enrolled under such plan or coverage, shall impose any cost-sharing requirements for such services.
II. For a health care contract that meets the definition of a "high deductible plan" set forth in 26 U.S.C. section 223(c)(2), this requirement shall apply only after the enrollee has satisfied the minimum deductible under section 223 for the year, except with respect to items or services that are preventive care pursuant to section 223(c)(2)(C) of the federal Internal Revenue Code, in which case paragraph I shall apply regardless of whether the minimum deductible under section 223 has been satisfied.
III. In this section:
(a) "Cost-sharing requirements" mean a deductible, coinsurance, copayment, and any maximum limitation on the application of such a deductible, coinsurance, copayment or similar out-of-pocket expense.
(b) "Diagnostic breast examination" means a medically necessary and appropriate examination of the breast, including such an examination using diagnostic mammography, breast magnetic resonance imaging, or breast ultrasound, that is:
(1) Used to evaluate an abnormality seen or suspected from a screening examination for breast cancer; or
(2) Used to evaluate an abnormality detected by another means of examination.
(c) "Supplemental breast examination" means a medically necessary and appropriate examination of the breast, including such an examination using breast magnetic resonance imaging, or breast ultrasound, that is:
(1) Used to screen for breast cancer when there is no abnormality seen or suspected; and
(2) Based on personal or family medical history, or additional factors that may increase the individual’s risk of breast cancer.
2 Effective Date. This act shall take effect 60 days after its passage.